Invesco Ltd. Avenue Therapeutics, Inc. Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 17, 2021
SELL
$2.41 - $7.11 $39,119 - $115,409
-16,232 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$4.7 - $7.17 $860 - $1,312
183 Added 1.14%
16,232 $99,000
Q4 2020

Feb 16, 2021
BUY
$2.95 - $11.04 $47,344 - $177,180
16,049 New
16,049 $95,000

About AVENUE THERAPEUTICS, INC.

ATXI Quotes by TradingView
  • Ticker ATXI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,127,720
  • Market Cap $8.13M
  • Description
  • Avenue Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, a synthetic dual-acting opioid, which is in Phase III clinical trials for the treatment of post-operative acute pain. The company was in...
More about ATXI
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email